Sinadjan, Rasil B.

HRN: 21-52-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
CEFTRIAXONE 1G (VIAL)
07/06/2022
07/12/2022
IV
2g
Q24H
UTI, T/C STI
Waiting Final Action 
07/06/2022
METRONIDAZOLE 500MG (TAB)
07/06/2022
07/12/2022
ORAL
500
Q8H
UTI, T/C STI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: